Medication info
Duo-Sustained Release Tablet 10/1000 mg

Duo-Sustained Release Tablet 10/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletDapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
AstraZeneca Korea
Appearance
Yellow to deep yellow, biconvex, oval, film-coated tablet
Packaging
30 tablets/box [(6 tablets/PTP)x5], 28 tablets/box [(7 tablets/PTP)x4]
Approval status
Active

MFDS item code 201503484 · Approved 2015.05.29 · Insurance code 650700930

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this product should be individualized based on the patient's current treatment, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This product is generally administered once daily with the evening meal. The maximum dose of this product is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients with no previous history of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy: When used as initial therapy in patients with no previous history of antidiabetic drug therapy, the recommended starting dose of this product is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be adjusted gradually to reduce gastrointestinal adverse effects of metformin. In patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this product should provide the patient's current metformin dose or the nearest appropriate therapeutic dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjusted appropriately. In patients switching from combination therapy with dapagliflozin and metformin to this product, treatment may be initiated at the existing doses of dapagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjusted appropriately. When this product is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Renal impairment No dosage adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this product, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this product is not recommended in patients with eGFR < 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) decreases to < 45 mL/min/1.73m2, this product should be discontinued immediately. Renal function should be evaluated every 3~6 months. Elderly patients Metformin is excreted by the kidneys, and renal function is likely to decline in elderly patients; therefore, this product should be used with caution with increasing age (see Precautions for Use, 9. Use in Elderly Patients).

Ingredients

Importer
AstraZeneca Korea

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • impaired blood glucose control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used in combination with diet and exercise to help control blood sugar in adult patients with type 2 diabetes. For patients whose blood sugar is not well controlled and who have cardiovascular disease or risk factors, careful guidance must be received regarding the effects of dapagliflozin on cardiovascular events. This medication is effective for the treatment of type 2 diabetes and helps improve blood glucose management.

How to take

Adult dose

The dose of this product should be individualized based on the patient's current treatment, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This product is generally administered once daily with the evening meal. The maximum dose of this product is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients with no previous history of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy: When used as initial therapy in patients with no previous history of antidiabetic drug therapy, the recommended starting dose of this product is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be adjusted gradually to reduce gastrointestinal adverse effects of metformin. In patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this product should provide the patient's current metformin dose or the nearest appropriate therapeutic dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjusted appropriately. In patients switching from combination therapy with dapagliflozin and metformin to this product, treatment may be initiated at the existing doses of dapagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjusted appropriately. When this product is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Renal impairment No dosage adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2 who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this product, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this product is not recommended in patients with eGFR < 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) decreases to < 45 mL/min/1.73m2, this product should be discontinued immediately. Renal function should be evaluated every 3~6 months. Elderly patients Metformin is excreted by the kidneys, and renal function is likely to decline in elderly patients; therefore, this product should be used with caution with increasing age (see Precautions for Use, 9. Use in Elderly Patients).

Precautions

This medication is a combination product used to help control blood glucose in patients with type 2 diabetes. While this medication is taken, it is necessary to be cautious as there is a very rare but serious risk of lactic acidosis, a dangerous condition that can occur. Lactic acidosis is a state where lactic acid is excessively accumulated in the body and leads to acidification, with symptoms such as shortness of breath, muscle pain, weakness, abdominal pain, requiring immediate treatment. Additionally, when taken with insulin or sulfonylureas, there is a risk of hypoglycemia, and blood sugar changes should be closely monitored. Patients with decreased renal function, especially those with moderate to severe renal dysfunction, should not use this medication, and those with unstable renal function need renal function tests before and during taking this medication. In acute diseases that may affect renal function, such as dehydration, severe infection, cardiac function deterioration, and acute myocardial infarction, this medication should be avoided. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication. This medication contains lactose, and patients with lactose intolerance or specific genetic metabolism disorders should not use it. During treatment, there may be an increased occurrence of genital infections and urinary tract infections, so cleanliness should be maintained, and if symptoms occur, immediate consultation with a physician is required. Hypotension or dehydration due to reduced fluid volume may occur, so especially elderly patients or those taking diuretics should periodically check blood pressure and fluid status. Vitamin B12 deficiency may occur, thus it is advisable to check serum vitamin B12 levels with long-term use. If there are plans for sudden surgery or tests using iodine contrast media during the period of taking this medication, temporarily discontinuing use and consulting healthcare professionals is recommended. Excessive alcohol consumption may increase the risk of side effects with this medication, so it should be avoided. Symptoms of hypoglycemia may appear, so if dizziness, cold sweat, or severe fatigue are felt, blood sugar should be checked immediately and necessary actions taken. The safety and efficacy of this medication in children have not been established, hence it should not be used in pediatric patients. During use, keep this medication out of reach of children and store it in its original container to maintain its quality.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • vulvovaginitis
  • balanitis
  • genital infection
  • urinary tract infection
  • fungal infection
  • hypoglycemia
  • volume depletion
  • thirst
Show 85 more
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • vulvar itching
  • genital itching
  • elevated hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • elevated blood urea
  • weight loss
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • rash
  • diarrhea
  • nausea
  • vomiting
  • vitamin B12 deficiency
  • Guillain-Barré syndrome
  • bacterial pneumonia
  • sialadenitis
  • tendinitis
  • chest pain
  • fever
  • burns
  • wrist fracture
  • gastrointestinal stromal tumor
  • pulmonary malignant neoplasm
  • uterine fibroids
  • atrial fibrillation
  • acute cholecystitis
  • epigastric pain
  • dyspepsia
  • abdominal discomfort
  • abdominal pain
  • gastric ulcer
  • irritable bowel syndrome
  • salivary gland mass
  • toothache
  • headache
  • facial paralysis
  • peripheral neuropathy
  • paresthesia
  • drowsiness
  • tremor
  • nasopharyngitis
  • pharyngitis
  • adenoviral conjunctivitis
  • shingles
  • pneumonia
  • rhinitis
  • increased alanine aminotransferase
  • increased blood sugar
  • arthralgia
  • myalgia
  • myofascial pain syndrome
  • osteoarthritis
  • osteochondrosis
  • limb pain
  • periarticular inflammation
  • tendinitis
  • trigger finger
  • weakness
  • fatigue
  • peripheral edema
  • edema
  • pain
  • vitamin D deficiency
  • hyperglycemia
  • urethral syndrome
  • cough
  • hyperventilation
  • itching
  • palpitations
  • insomnia
  • type 2a hyperlipidemia
  • sensorineural hearing loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow to deep yellow, biconvex, oval, film-coated tablet

Package unit

30 tablets/box [(6 tablets/PTP)x5], 28 tablets/box [(7 tablets/PTP)x4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.